Trends and perspectives in pancreas and simultaneous pancreas and kidney transplantation

Current Opinion in Urology

Volumn 11, Issue 2, 2001, Pages 165-174

  Kahl, Andreas ^a   Bechstein, Wolf Otto ^b   Frei, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0035111671     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200103000-00007     Document Type: Review

References (136)

1. Lifetime benefits and costs of intensive therapy as practised in the diabetes control and complications trial
2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
3. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
4. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy
5. Experience with 500 simultaneous pancreas-kidney transplants
6. Simultaneous cadaver pancreas livingdonor kidney transplantation: A new approach for the type 1 diabetic uremic patient
7. Simultaneous kidney and segmental pancreas transplants from living related donors - The first two successful cases
8. Simultaneous pancreas-kidney transplantation from live donors
9. Pancreas transplantation for diabetes mellitus
10. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels
11. Simultaneous pancreas and kidney transplantation in a type II (non-insulin-dependent) diabetic uremic requiring pregraft insulin
12. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus
13. Reversal of lesions of diabetic nephropathy after pancreas transplantation
14. Pancreaticocystostomy: An alternative method for exocrine drainage of segmental pancreatic allografts
15. Conversion from bladder to enteric drainage after pancreaticoduodenal transplantations
16. Results of pancreas transplantation with portal venous and enteric drainage
17. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition
18. Effects of portal versus systemic venous drainage in kidney-pancreas recipients
19. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation
20. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation
21. Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: Clinical outcome of 40 consecutive transplant recipients
22. Surgical complications requiring early relaparotomy after pancreas transplantation: A multivariate risk factor and economic impact analysis of the cyclosporine A era
23. Analysis of mortality after pancreas transplantation
24. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts
25. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation
26. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation
27. Serum lipase as a marker for pancreatic allograft rejection
28. Early detection of rejection in pancreas transplantation
29. Correlation between cystoscopic biopsy results and hypoamylasuria in bladder-drained pancreas transplants
30. Kidney-pancreas transplantation for diabetic nephropathy
31. Magnetic resonance imaging and Levovist-enhanced colour and power Doppler imaging in the follow-up of pancreas transplants in patients after combined pancreas and kidney transplantation
32. Correlation of the arterial resistive index in pancreas transplants of patients with transplant rejection
33. Pancreas allograft rejection: Correlation of transduodenal core biopsy with Doppler resistive index
34. Acute pancreatic transplant rejection: Evaluation with dynamic contrast-enhanced MR imaging compared histopathologic analysis
35. Diagnosis of pancreas rejection: Cystoscopic transduodenal versus percutaneous computed tomography scan-guided biopsy
36. Laparoscopic biopsy after pancreaticoduodenal transplantation. A first report
37. Use of ultrasound and cystoscopically guided pancreatic allograft biopsies and transabdominal renal allograft biopsies: Safety and efficacy in kidney-pancreas transplant recipients
38. Cystoscopic biopsies in pancreaticoduodenal transplantation. Are duodenal biopsies indicative of pancreas dysfunction?
39. Evaluation of pancreas transplant needle biopsy. Reproducibility and revision of histologic grading system
40. Chronic pancreas allograff rejection: Morphologic evidence of progression in needle biopsies and proposal of a grading scheme
41. Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients
42. Renal allograft and patient outcome after transplantation; pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients
43. Review of immunosuppressive usage in pancreas transplantation
44. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation
45. Maintenance immunosuppression without corticosteroids following combined pancreas and kidney transplantation
46. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine A-treated renal transplant recipients
47. Long term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus and mycophenolate mofetil
48. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression
49. Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: Results of a prospective pilot study in 28 consecutive cases
50. Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: Initial experience in 50 consecutive cases
51. Tacrolimus in pancreas transplantation: A multicenter analysis
52. FK 506 induction and rescue therapy in pancreas transplant
53. Tacrolimus versus cyclosporine A in primary simultaneous pancreas kidney (SPK) transplantation. Preliminary results of 3 month
54. Sirolimus-tacrolimus combination immunosuppression
55. Management strategies for nephrotoxicity
56. An open-label comparative trial of two daclizumab dosing strategies versus no antibody induction combined with tacrolimus (TAC) mycophenolate mofetil (MMF) and steroids for the prevention of acute rejection in simultaneous kidney/pancreas (SPKT) recipients: Interim analysis
57. A multicenter trial of Simulect® in combination with Neoral®, Cellcept® and steroids for the prevention of acute rejection in kidney pancreas transplantation: A low rate of rejection without recurrent diabetes mellitus
58. Management choices in diabetic end-stage renal disease
59. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients
60. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
61. Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients
62. Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation
63. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation
64. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure
65. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with endstage renal disease
66. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: Is there a difference in survival?
67. High survival rates of kidney transplants from spousal and living unrelated donors
68. Kidney transplantation in diabetic patients: The University of Minnesota experience
69. An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation
70. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes
71. Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect
72. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys
73. Metabolic characterization of long-term successful pancreas transplants in type 1 diabetes
74. Glucose, insulin, and glucagon levels during exercise in pancreas transplant recipients
75. First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation
76. Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation
77. Effects of pancreas transplantation on late complications of diabetes and metabolic effects of pancreas and islet transplantation
78. Glucagon, catecholamine and pancreatic polypeptide secretion in type 1 diabetic recipients of pancreas allografts
79. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type 1 diabetes and autonomic neuropathy
80. Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus
81. Hypoglycemia after pancreas transplantation
82. Anti-insulin antibodies may cause hypoglycaemia following pancreas transplantation
83. Clinical determinants of glucose homeostasis after pancreas transplantation
84. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: Outcome in 70 consecutive cases
85. Hepatic insulin resistance after pancreas transplantation in type 1 diabetes
86. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients
87. Lack of feedback inhibition of insulin secretion in denervated human pancreas
88. Post-transplant diabetes mellitus. The role of immunosuppression
89. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients
90. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation
91. Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation
92. Hyperinsulinemia as an independent risk factor for ischemic heart disease
93. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: A critical appraisal
94. Hyperinsulinemia and atherosclerosis
95. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
96. Lipoprotein profile after combined kidney-pancreas transplantation in insulin dependent diabetes mellitus
97. Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients
98. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients
99. Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation
100. Pancreas transplantation modulates reverse cholesterol transport
101. Differing effects of pancreas-kidney transplantation with systemic versus portal venous drainage on cholesteryl ester transfer in IDDM subjects
102. Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabeticuremic patients
103. Increasing prevalence of cardiovascular disease in kidney transplant patients with Type 1 diabetes
104. Cardiovascular risk in diabetes: A brief review
105. Safe pancreas transplantation in patients with coronary artery disease
106. Progression of macrovascular disease after transplantation
107. Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease
108. Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease
109. Foot problems in the diabetic transplant recipient
110. Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients
111. Sustained improvement in cardiac function 24 months following pancreas-kidney transplant
112. Efficacy of pancreatic transplantation on cardiovascular alterations in diabetic rats: An ultrastructural and immunohisteohemical study
113. Microangiopathy reversal in successful simultaneous pancreas-kidney transplantation
114. Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: A computer-assisted intravital microscopy study on the conjunctival microcirculation
115. Improvement of glucose/insulin metabolism reduces hypertension in insulin-dependent diabetes mellitus recipients of kidney-pancreas transplantation
116. Hypertension with combined pancreas-kidney transplantation in patients with diabetic nephropathy
117. Bladder drained pancreas improves arterial hypertension in patients with simultaneous pancreas and kidney transplantation (SPK)
118. Hypertension after pancreas-kidney transplantation: Role of bladder versus enteric pancreatic drainage
119. Effects of intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of prospective controlled 10-year study
120. Neuropathy and mortality in diabetes: Influence of pancreas transplantation
121. Long-term effects of pancreatic transplantation on diabetic neuropathy
122. Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant
123. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life
124. Preliminary experience with midodrine in kidney/pancreas transplant patients with orhostatic hypotension
125. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series
126. Diabetic retinopathy after combined kidney-pancreas transplantation
127. Diabetic retinopathy and pancreas transplantation: A 3-year follow-up
128. Quality of life after pancreas transplantation: A review
129. Reproductive hormones after pancreas transplantation
130. Pregnancy outcomes in female pancreas-kidney recipients
131. Pregnancy after pancreas transplantation in the cyclosporine era: Report from the International Pancreas Transplant Registry
132. An economic analysis of pancreas transplantation: Costs, insurance coverage, and reimbursement
133. Analysis of hospital charges after simultaneous pancreas-kidney transplantation in the era of managed care
134. The effectiveness of a transplant outpatient unit as a cost-reducing strategy following pancreas transplantation
135. Treatment strategies for insulin-dependent diabetics with ESRD: A cost-effectiveness decision analysis model